Data Bridge Market Research

  Global clinical trial management system (CTMS) market in the forecast period are the rise in operational costs and regulatory requirements regarding the clinical research. Furthermore, the research partnerships between pharma-biopharma companies and CROs is further anticipated to propel the growth of the clinical trial management system (CTMS) market. Moreover, rise in the number of clinical trials and the availability of advanced CTMS solutions and the growing government funding and grants to support clinical trials is further estimated to cushion the growth of the global clinical trial management system (CTMS) market. On the other hand, the constraint in the budget is further projected to impede the growth of the global clinical trial management system (CTMS) market in the timeline period. Data Bridge Market Research analyses that the global clinical trial management system (CTMS) market which was USD 1,120.48 million in 2023, would rocket up to USD 3,012.39 million by 2030, an

  The market for DNA fragmentation technique is expected to grow during the forecast period. The most important factors fuelling the growth of the global market for advanced DNA fragmentation techniques include rising public awareness of the benefits and availability of these techniques, an increase in patients with lifestyle diseases and obesity, rising adoption of improved and more advanced assisted reproductive technologies, and a rise in the world's geriatric population. Data Bridge Market Research analyses that the DNA fragmentation technique market which was USD 5.89 billion in 2021, would rocket up to USD 14.48 billion by 2029, and is expected to undergo a CAGR of 11.90% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epid